LUMEXA IMAGING HOLDINGS ($LMRI) posted quarterly earnings results for Q1 2026 on Tuesday, May 12th. The company reported earnings of $0.18 per share, beating estimates of $0.12 by $0.06. The company also reported revenue of $252,540,000, missing estimates of $256,024,518 by $-3,484,518.
You can see Quiver Quantitative's $LMRI stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
LUMEXA IMAGING HOLDINGS Hedge Fund Activity
We have seen 67 institutional investors add shares of LUMEXA IMAGING HOLDINGS stock to their portfolio, and 5 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ALLIANCEBERNSTEIN L.P. added 3,238,479 shares (+inf%) to their portfolio in Q4 2025, for an estimated $59,911,861
- JANUS HENDERSON GROUP PLC added 1,992,453 shares (+inf%) to their portfolio in Q4 2025, for an estimated $36,860,380
- HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND added 1,500,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $27,750,000
- ARROWMARK COLORADO HOLDINGS LLC added 1,500,000 shares (+inf%) to their portfolio in Q4 2025, for an estimated $27,750,000
- INVESCO LTD. added 1,435,807 shares (+inf%) to their portfolio in Q4 2025, for an estimated $26,562,429
- MILLENNIUM MANAGEMENT LLC added 1,290,664 shares (+inf%) to their portfolio in Q4 2025, for an estimated $23,877,284
- BALYASNY ASSET MANAGEMENT L.P. added 1,134,572 shares (+inf%) to their portfolio in Q4 2025, for an estimated $20,989,582
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
LUMEXA IMAGING HOLDINGS Analyst Ratings
Wall Street analysts have issued reports on $LMRI in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- William Blair issued a "Outperform" rating on 01/05/2026
To track analyst ratings and price targets for LUMEXA IMAGING HOLDINGS, check out Quiver Quantitative's $LMRI forecast page.
LUMEXA IMAGING HOLDINGS Price Targets
Multiple analysts have issued price targets for $LMRI recently. We have seen 7 analysts offer price targets for $LMRI in the last 6 months, with a median target of $23.0.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $15.0 on 04/14/2026
- John Ransom from Raymond James set a target price of $23.0 on 02/09/2026
- An analyst from Wells Fargo set a target price of $22.0 on 01/05/2026
- Pito Chickering from Deutsche Bank set a target price of $22.0 on 01/05/2026
- An analyst from Leerink Partners set a target price of $23.0 on 01/05/2026
- Brian Tanquilut from Jefferies set a target price of $23.0 on 01/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
